Next raise will be around 2.75 IMO. Their is a lot of interest in the pipeline with Big pharma. Additionally Sigma Tau and others hold most of the stock in a very thin float situation.My year end target is 5.00 plus and a lot higher if results of sgx 942 are good.
major product now launched. IMO big Eye care company buys out NBY. They cannot afford not to. They are all hurting and need a new dynamic product. I hope they sell the rights to the phase 2 cathether results. Its ready for a phase 3 and is worth 20 million to NBY. IMo
I think its good. IMO Stock could rock. Hoping for $3.00 and then a money raise.